Antibodies specifically directed to a soluble form of CTLA-4
| dc.contributor.institution | University of Aberdeen.Medical Sciences | en |
| dc.contributor.institution | University of Aberdeen.Applied Medicine | en |
| dc.contributor.inventor | Ward, Frank James | |
| dc.contributor.inventor | Barker, Robert Norman | |
| dc.contributor.inventor | Dahal, Lekh Nath | |
| dc.date.accessioned | 2019-09-09T14:00:09Z | |
| dc.date.available | 2019-09-09T14:00:09Z | |
| dc.date.issued | 2010-09-02 | |
| dc.description | New antibody molecule that binds specifically to soluble form of cytotoxic T-lymphocyte antigen, useful as vaccine e.g. to enhance antigen specific immune response against pathogens e.g. bacteria, virus e.g. HIV, and nematode Patent Number(s): WO2010097597-A1 Original ; AU2010217453-A1 ; EP2401035-A1 Original ; CN102421482-A ; US2012107320-A1 Original ; CA2772648-A1 ; JP2012518425-W ; IN201106831-P4 ; US8697845-B2 Original ; JP5864266-B2 ; CN102421482-B ; AU2010217453-B2 ; EP2401035-B1 Original ; ES2662652-T3 | en |
| dc.format.extent | 1461314 | |
| dc.identifier | 100909706 | |
| dc.identifier | 2517a5b3-75cc-4fb4-845b-576ae597911b | |
| dc.identifier | US8697845 B2 | |
| dc.identifier.citation | Ward, F J, Barker, R N & Dahal, L N Sept. 02 2010, Antibodies specifically directed to a soluble form of CTLA-4, Patent No. US8697845 B2. | en |
| dc.identifier.uri | http://hdl.handle.net/2164/12875 | |
| dc.identifier.url | https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20140415&DB=EPODOC&locale=en_EP&CC=US&NR=8697845B2&KC=B2&ND=5 | en |
| dc.language.iso | eng | |
| dc.subject | R Medicine | en |
| dc.subject.lcc | R | en |
| dc.title | Antibodies specifically directed to a soluble form of CTLA-4 | en |
| dc.type | Patent | en |